Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad-p53 DC Vaccine in Extensive Stage SCLC
NCT00049218Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Apr 2003
- Primary completion
- Jun 2007
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Ad.p53-DC vaccine in small cell lung cancer (SCLC), sponsored by Moffitt Cancer Center. Started Apr 2003; status: completed.
02
Drugs
Ad.p53-DC vaccine
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00049218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049218.